RaeSedo, has been awarded $3.4 million to advance new asthma therapies originally developed at the UArizona College of Medicine – Tucson and the BIO5 Institute.

Dr. Julie Ledford will help lead the Clinical Translational Sciences Graduate Program, which prepares students for careers in research relevant to human health and disease.

More than 4 UAHS faculty have found the joy of discovering how to bring their research to patients who need it through a global collaboration institute.

Wil Pederson, a UArizona doctoral student, is using the Infection and Inflammation as Drivers of Aging training program to investigate menopause-onset asthma.

Despite slowdowns in research suffered by universities around the world due to the pandemic, the University of Arizona has experienced solid growth in the commercialization of university inventions.

Though trained at rival institutions, Drs. Julie Ledford and Michael Johnson formed a friendship over a mutual love of science and their daughters that has led to an RO1 grant and recent publication.

The AZ Center for Drug Discovery and the UACC hosted, “Discovering New Medicines in Arizona,” highlighting research seeking to discover effective drug candidates to treat diseases prevalent in Arizona.

More so than others, obese asthma patients struggle with control of their disease — and symptoms that worsen with time. A team of researchers found an explanation and has begun developing a therapy to address it.

BIO5 Researchers Drs. Julie Ledford and Monica Kraft, are looking to genetics as a possible new treatment for Asthma. They’re studying the protein surfactant, which is one of the most abundant proteins in the lungs and is known for helping people clear ou

A UA clinician team made up of BIO5 members Drs. Julie Ledford Monica Kraft, use genetics as a guide focused on turning research into new treatments for asthma and other lung diseases.